AVP of Safety and Transformation at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, HealthcareIndustries

Requirements

  • Transformational yet execution-focused leader capable of articulating compelling vision
  • Ability to build stakeholder confidence and navigate complex global organizations
  • Experience delivering measurable results in a highly regulated environment
  • Expertise in pharmaceutical innovation, drug development, patient safety, and pharmacovigilance
  • Knowledge of technology strategy, IT operating models, automation, AI, and advanced analytics
  • Experience leading service management transformation and organizational change
  • Strategic oversight in Asia R&D markets (China, Japan, Singapore) with ability to harmonize global and regional requirements
  • Capability to identify high-value AI use cases, guide proof-of-concepts, and scale innovations

Responsibilities

  • Lead enterprise strategy for drug safety technology systems and pharmacovigilance capabilities, including continuous modernization to meet regulatory and business needs
  • Drive service management transformation utilizing the Global Capability Center in India, including assessing/simplifying workflows, insourcing, and adopting automation/AI
  • Provide strategic direction, oversight, and execution for R&D technology teams in Asia (China, Japan, Singapore), ensuring harmonization with global innovation
  • Champion AI and advanced analytics integration across patient safety, pharmacovigilance, service management, and Asia R&D workflows and platforms
  • Define and execute multi-year technology strategies for patient safety, Asia R&D, and related domains aligned with corporate objectives and R&D priorities
  • Partner with senior R&D and business leaders to transform technology enabling patient safety and operational efficiency
  • Lead a high-performing global team with accountability across the US and key Asian markets
  • Balance strategic leadership with hands-on execution to deliver productivity, quality, speed improvements, and faster/safer delivery of medicines

Skills

Key technologies and capabilities for this role

PharmacovigilancePatient SafetyTechnology StrategyService ManagementWorkflow TransformationGlobal Capability CenterDrug Safety SystemsRegulatory Compliance

Questions & Answers

Common questions about this position

Is this position remote or based in a specific location?

The role is based in Indianapolis, Indiana, with global accountability spanning the United States and key Asian markets.

What are the main responsibilities of this AVP role?

The role involves leading patient safety and pharmacovigilance technology strategy, service management transformation using the Global Capability Center in India, Asia R&D technology strategy across China, Japan, and Singapore, and championing AI and innovation integration.

What skills or experience are required for this position?

This information is not specified in the job description.

What is the salary or compensation for this role?

This information is not specified in the job description.

What does Eli Lilly's company culture emphasize?

Lilly unites caring with discovery to make life better for people around the world, puts people first, and seeks determined individuals who give their best effort to their work.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI